Neil Riordan, PA, PhD Presents at the 5th Annual Perinatal Stem Cell Society Congress in Salt Lake City, UT on Thursday, February 28th

Neil Riordan, PA, PhD presented “Results From Panama Clinical Trials Using Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells (HUCT-MSCs) for Multiple Sclerosis and Autism” at the 5th Annual Perinatal Stem Cell Society Congress in Salt Lake City, UT on Thursday, February 28th. Neil Riordan, PA, PhD SALT LAKE CITY (PRWEB) MARCH 01, 2019Neil Riordan, [...]

Applied Stem Cell Therapy Expert, Neil Riordan, PhD, Authors “Cell Therapy for Liver Failure: A New Horizon” in Contemporary Liver Transplantation Medical Reference

DALLAS-FORT WORTH, TEXAS (PRWEB) NOVEMBER 08, 2016 (Original Press Release on PRWeb) Neil Riordan, PhD A new chapter by renowned applied stem cell therapy expert, Neil Riordan, PhD of the Riordan-McKenna Institute in Southlake, Texas; Medistem Labs Panama, and the Stem Cell Institute in Panama City, Panama, entitled, “Cell Therapy for Liver Failure: A [...]

FDA poised to outlaw breast reconstruction for breast cancer survivors using their own fat tissue

The U.S. Food and Drug Administration held public hearings for two days this week to allow for public commenting on proposed guidance relating to the regulation of human cells, tissues or tissue-based products. In its current form, this guidance will classify a woman’s own fat tissue as a drug when used in breast reconstruction procedures. [...]

2016-09-15T16:40:41+00:00September 15th, 2016|Bone Marrow Stem Cells, Breast Cancer, Cancer, FDA, News|

Stem cell pioneer sets sights on Japan – Japan Times features Neil Riordan, PhD of Medistem Panama

"We enjoy the advantage of having a large amount of clinical data on 2,000 patients. So we analyzed who received which cells and which cells worked best in different conditions. This allowed us to create our selection process through molecular profiling,” explained Medistem (Panama) Founder and CEO Dr. Neil Riordan. Operating what is arguably the [...]

US FDA Green Lights Second Duchenne’s Muscular Dystrophy Patient To Receive Human Umbilical Cord Stem Cells In US

(PRWEB) MAY 26, 2016 After several promising treatments in Panama using stem cell technology developed by Medistem Panama Inc. at the City of Knowledge in Panama, a 6 year-old Duchenne’s muscular dystrophy patient received his first umbilical cord tissue-derived mesenchymal stem cells in the US earlier this year following FDA approval of a second application [...]

What are the sources of the stem cells used at Stem Cell Institute in Panama?

Lately, especially on our Facebook Page many people are asking us, "What is the source of the stem cells?" At the Stem Cell Institute, we use two types of stem cells. Primarily, we use allogeneic mesenchymal stem cells harvested from human umbilical cord tissue. In addition to allogeneic mesenchymal stem cells, our spinal cord injury [...]

Colton’s walking after stem cell therapy for cerebral palsy in Panama

Colton is planning on coming to Panama for follow-up treatment later this year. Here is a video of him walking from June 2015. And here was Colton in 2014 about one year prior to the video above. This video was taken a year after his first treatments in 2013. To keep up with Colton's progress [...]

Duchenne’s Patient Ryan Benton Discusses His Experience with Stem Cell Therapy

Ryan Benton is the first patient in the United States to receive human umbilical cord-derived mesenchymal stem cell therapy for Duchenne's muscular dystrophy. The US FDA granted Ryan this trial under compassionate use. Ryan first began treatments at the Stem Cell Institute in Panama before being able to receive treatments in his hometown of Wichita, [...]

2015-02-17T00:59:43+00:00February 17th, 2015|Duchenne's muscular dystrophy, News, Stem Cell Research|

Inside High School Football Report on Hall of Fame Coach and Stem Cell Recipient, Sam Harrell

Sam, who suffers from multiple sclerosis, was forced to retire as Ennis (Texas) High School's head football coach due to his debilitating symptoms. Sam's first two treatments using stem cells harvested from his own fat did not yield long lasting, positive results. However, after his third and fourth trips to the Stem Cell Institute in [...]

Stem Cell Therapy for Multiple Sclerosis: Ron McGill

Ron McGill suffers from relapsing-remitting multiple sclerosis. He was started experiencing symptoms in 2009 but was not diagnosed with MS until January of 2013. He received several infusion and injections of human umbilical cord-tissue derived stem cells at the Stem Cell Institute in late October and Early November 2013. In this video, Ron shares his [...]